What is asthma? Pathophysiology, demographics, and health care costs

Otolaryngologic Clinics of North America

Volumn 47, Issue 1, 2014, Pages 13-22

  Maslan, Jonathan ^a   Mims, James W ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Asthma; Costs; Demographics; Epidemiology; Pathogenesis; Pathophysiology

Indexed keywords

AIRWAY OBSTRUCTION; AIRWAY REMODELING; ALLERGIC RHINITIS; ASTHMA; BRONCHIOLITIS; BRONCHOSPASM; CELL TYPE; CHEST TIGHTNESS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COUGHING; CYSTIC FIBROSIS; DIFFERENTIAL DIAGNOSIS; DYSPNEA; EDEMA; EOSINOPHIL; EPITHELIUM CELL; FORCED EXPIRATORY VOLUME; FOREIGN BODY ASPIRATION; GASTROESOPHAGEAL REFLUX; GENE EXPRESSION; HEALTH CARE COST; HUMAN; INFLAMMATION; LYMPHOCYTE; MACROPHAGE; MAST CELL; NEUTROPHIL; OTOLARYNGOLOGIST; PATHOPHYSIOLOGY; PHENOTYPE; PREVALENCE; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION; REVIEW; RISK FACTOR; SINUSITIS; TH2 CELL; TRACHEOMALACIA; UNITED STATES; VOCAL CORD DISORDER; WHEEZING;

ASTHMA; COSTS; DEMOGRAPHICS; EPIDEMIOLOGY; PATHOGENESIS; PATHOPHYSIOLOGY;

AIRWAY OBSTRUCTION; AIRWAY RESISTANCE; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHIAL HYPERREACTIVITY; ENVIRONMENTAL POLLUTION; FEMALE; HEALTH CARE COSTS; HUMANS; INFLAMMATION MEDIATORS; MALE; RADIOGRAPHY, THORACIC; RECURRENCE; RESPIRATORY FUNCTION TESTS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; WORLD HEALTH;

EID: 84888831683     PISSN: 00306665     EISSN: 15578259     Source Type: Journal    
DOI: 10.1016/j.otc.2013.09.010     Document Type: Review

References (47)

1. Osler W. The principles and practice of medicine 1920, D. Appleton and Company, New York, London.
2. Eder W., Ege M.J., von Mutius E. The asthma epidemic. NEngl J Med 2006, 355:2226-2235.
3. Busse W.W., et al. Expert Panel Report Three. Guidelines for the diagnosis and management of asthma 2007, National Institutes of Health.
4. Fuhlbrigge A.L., Kitch B.T., Paltiel A.D., et al. FEV(1) is associated with risk of asthma attacks in a pediatric population. JAllergy Clin Immunol 2001, 107:61-67.
5. Cohn L., Elias J.A., Chupp G.L. Asthma: mechanisms of disease persistence and progression. Annu Rev Immunol 2004, 22:789-815.
6. Handoyo S., Rosenwasser L.J. Asthma phenotypes. Curr Allergy Asthma Rep 2009, 9:439-445.
7. Novak N., Bieber T. Allergic and nonallergic forms of atopic diseases. JAllergy Clin Immunol 2003, 112:252-262.
8. Romanet-Manent S., Charpin D., Magnan A., et al. Allergic vs nonallergic asthma: what makes the difference?. Allergy 2002, 57:607-613.
9. Holgate S.T., Polosa R. The mechanisms, diagnosis, and management of severe asthma in adults. Lancet 2006, 368:780-793.
10. Bachert C., Vignola A.M., Gevaert P., et al. Allergic rhinitis, rhinosinusitis, and asthma: one airway disease. Immunol Allergy Clin North Am 2004, 24:19-43.
11. Dixon A.E., Kaminsky D.A., Holbrook J.T., et al. Allergic rhinitis and sinusitis in asthma: differential effects on symptoms and pulmonary function. Chest 2006, 130:429-435.
12. Corren J. Allergic rhinitis and asthma: how important is the link?. JAllergy Clin Immunol 1997, 99:S781-S786.
13. Roberts C.R., Okazawa M., Wiggs B., et al. Airway wall thickening. Asthma 1997, 925-935. Raven Publishers, Philadelphia. P.J. Barnes, M.M. Grunstein, A.R. Leff (Eds.).
14. Homer R.J., Elias J.A. Consequences of long-term inflammation. Airway remodeling. Clin Chest Med 2000, 21:331-343. ix.
15. Krouse J.H., Brown R.W., Fineman S.M., et al. Asthma and the unified airway. Otolaryngol Head Neck Surg 2007, 136:S75-S106.
16. Chakir J., Shannon J., Molet S., et al. Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression. JAllergy Clin Immunol 2003, 111:1293-1298.
17. Dhong H.J., Kim H.Y., Cho D.Y. Histopathologic characteristics of chronic sinusitis with bronchial asthma. Acta Otolaryngol 2005, 125:169-176.
18. Pohunek P., Warner J.O., Turzíková J., et al. Markers of eosinophilic inflammation and tissue re-modelling in children before clinically diagnosed bronchial asthma. Pediatr Allergy Immunol 2005, 16:43-51.
19. van Den Toorn L.M., Prins J.B., Overbeek S.E., et al. Adolescents in clinical remission of atopic asthma have elevated exhaled nitric oxide levels and bronchial hyperresponsiveness. Am J Respir Crit Care Med 2000, 162:953-957.
20. van den Toorn L.M., Overbeek S.E., de Jongste J.C., et al. Airway inflammation is present during clinical remission of atopic asthma. Am J Respir Crit Care Med 2001, 164:2107-2113.
21. van den Toorn L.M., Overbeek S.E., Prins J.B., et al. Asthma remission: does it exist?. Curr Opin Pulm Med 2003, 9:15-20.
22. Busse W.W., Lemanske R.F. Asthma. NEngl J Med 2001, 344:350-362.
23. Stevenson D.D., Szczeklik A. Clinical and pathologic perspectives on aspirin sensitivity and asthma. JAllergy Clin Immunol 2006, 118:773-786. [quiz: 787-8].
24. Vally H., Taylor M.L., Thompson P.J. The prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patients. Thorax 2002, 57:569-574.
25. Vercelli D. Discovering susceptibility genes for asthma and allergy. Nat Rev Immunol 2008, 8:169-182.
26. Weiss S.T., Raby B.A., Rogers A. Asthma genetics and genomics 2009. Curr Opin Genet Dev 2009, 19:279-282.
27. Wang H.Y., Wong G.W., Chen Y.Z., et al. Prevalence of asthma among Chinese adolescents living in Canada and in China. CMAJ 2008, 179:1133-1142.
28. von Mutius E., Martinez F.D., Fritzsch C., et al. Prevalence of asthma and atopy in two areas of West and East Germany. Am J Respir Crit Care Med 1994, 149:358-364.
29. Priftanji A., Strachan D., Burr M., et al. Asthma and allergy in Albania and the UK. Lancet 2001, 358:1426-1427.
30. Lau S., Illi S., Sommerfeld C., et al. Early exposure to house-dust mite and cat allergens and development of childhood asthma: a cohort study. Multicentre Allergy Study Group. Lancet 2000, 356:1392-1397.
31. Sears M.R., Herbison G.P., Holdaway M.D., et al. The relative risks of sensitivity to grass pollen, house dust mite and cat dander in the development of childhood asthma. Clin Exp Allergy 1989, 19:419-424.
32. Strachan D.P., Cook D.G. Health effects of passive smoking. 6. Parental smoking and childhood asthma: longitudinal and case-control studies. Thorax 1998, 53:204-212.
33. Strachan D.P., Butland B.K., Anderson H.R. Incidence and prognosis of asthma and wheezing illness from early childhood to age 33 in a national British cohort. BMJ 1996, 312:1195-1199.
34. Patel M.M., Miller R.L. Air pollution and childhood asthma: recent advances and future directions. Curr Opin Pediatr 2009, 21:235-242.
35. Corne J.M., Marshall C., Smith S., et al. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet 2002, 359:831-834.
36. von Mutius E. Infection: friend or foe in the development of atopy and asthma? The epidemiological evidence. Eur Respir J 2001, 18:872-881.
37. Braun-Fahrländer C., Lauener R. Farming and protective agents against allergy and asthma. Clin Exp Allergy 2003, 33:409-411.
38. Keeley D.J., Neill P., Gallivan S. Comparison of the prevalence of reversible airways obstruction in rural and urban Zimbabwean children. Thorax 1991, 46:549-553.
39. van Strien R.T., Engel R., Holst O., et al. Microbial exposure of rural school children, as assessed by levels of N-acetyl-muramic acid in mattress dust, and its association with respiratory health. JAllergy Clin Immunol 2004, 113:860-867.
40. Asher M.I., Montefort S., Björkstén B., et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006, 368:733-743.
41. Janson C., Anto J., Burney P., et al. The European Community Respiratory Health Survey: what are the main results so far? European Community Respiratory Health Survey II. Eur Respir J 2001, 18:598-611.
42. Subbarao P., Mandhane P.J., Sears M.R. Asthma: epidemiology, etiology and risk factors. CMAJ 2009, 181:E181-E190.
43. Centers for Disease Control and Prevention. Behavioral risk factor surveillance survey. Available at: . Accessed July 4, 2013. http://www.lung.org/lung-disease/asthma/resources/facts-and-figures/asthma-children-fact-sheet.html.
44. Centers for Disease Control and Prevention. CDC vital signs. 2013. Available at: . Accessed July 4, 2013. http://www.cdc.gov/VitalSigns/Asthma/index.html.
45. Barnett S.B., Nurmagambetov T.A. Costs of asthma in the United States: 2002-2007. JAllergy Clin Immunol 2011, 127:145-152.
46. Centers for Disease Control and Prevention. National Center for Health Statistics, National Hospital Discharge Survey, 1995-2010. 2013. Available at: . Accessed July 4, 2013. http://www.lung.org/lung-disease/asthma/resources/facts-and-figures/asthma-children-fact-sheet.html.
47. Centers for Disease Control and Prevention. Statistics. Compiled from Compressed Mortality File 1999-2009 Series 1920 No. 1920.